2m 2m 2m 2m 2m 2m 2m
Axsome Therapeut (AXSM)
NASDAQ
$228.37+$0.09 (+0.04%)
Price as of Jul 14, 2026 4:47 AM EDT- $11.7BMarket Cap
- 103.22%1-Year Change
- BiotechnologyIndustry
Axsome Therapeut (AXSM)
$228.37+$0.09 (+0.04%)
AXSM | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $228.28 | ||
Change | -$5.52 (-2.36%) | ||
Open | $230.15 | ||
High | $231.81 | ||
Low | $224.70 | ||
Previous Close | $233.80 | ||
Volume | 843,010 | ||
30-Day Average Volume | 1,258,591 | ||
1-Week Change | -5.90% | ||
1-Month Change | -10.54% | ||
1-Year Change | 103.22% | ||
3-Year Change | 212.71% | ||
5-Year Change | 259.95% | ||
Fundamentals | |||
Shares Outstanding | 51.5M | ||
Total Assets | $713.6M | ||
Market Cap | $11.7B | ||
Enterprise Value | $11.6B | ||
Period: QTR TTM FY | |||
Revenue | $189.4M | ||
Net Income | -$64.5M | ||
Free Cash Flow | -$20.8M | ||
EBIT | -$61.5M | ||
EBITDA | -$59.9M | ||
Net Working Capital | $172.0M | ||
EPS | -$1.26 | ||
Enterprise Value/EBITDA | -194 | ||
Enterprise Value/Revenue | 61 | ||
P/B | 215 | ||
P/E | -181 | ||
PEG | 1 | ||
Price/Free Cash Flow | -564 | ||
Price/Operating Cash Flow | -567 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue